Condition: Cochlear Implant · Sponsor: MED-EL Elektromedizinische Geräte GesmbH
The newly developed MED-EL Cochlear Implant Mi1250 +FLEX28 DEX (CIDEXEL) incorporates the anti-inflammatory agent dexamethasone (DEX) into the electrode array. The passive elution of DEX during the post-implantation period has the purpose of counteracting the increase of the post-operative impedance induced by the insertion trauma. The aim of this clinical investigation is to obtain confirmatory data concerning safety and performances of the investigational device in the clinical population.
This description comes directly from the study's public registry record.
Stefano Morettini, PhD · +43664607051034 · stefano.morettini@medel.com
Always discuss trial participation with your own doctor first.
| HNO-Klinik der Ruhr-Universität Bochum | Bochum, Germany | Recruiting |
| Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde | Dresden, Germany | Recruiting |
| Universitätsklinikum Frankfurt Klinik für HNO-Heilkunde | Frankfurt, Germany | Recruiting |
| Martin-Luther-Universität Halle-Wittenberg, Universitätsklinik und Poliklinik für Hals-Nasen-OhrenHeilkunde, Kopf- und Hals-Chirurgie | Halle, Germany | Recruiting |
| HNO-Klinik der Medizinischen Hochschule Hannover | Hanover, Germany | Recruiting |
| Universitätsklinik für Hals-, Nasen- und Ohrenheilkunde | Tübingen, Germany | Recruiting |
| Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen. Die Universitäts-HNO-Klinik Würzburg | Würzburg, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06142682